Bhavesh Balar, MD
Board Certifications: Medical Oncology and Hematology
Languages: Guajarati, Hindi and English
Locations: Freehold, NJ
Call Freehold, NJ: (732) 431-8400
Bhavesh Balar, MD, is a medical oncologist who serves patients at Regional Cancer Care Associates (RCCA) in Freehold, NJ. He has nearly 20 years of experience in treating a wide variety of cancer types and blood disorders with an emphasis on compassionate, comprehensive care. Using the latest cutting-edge developments, he helps patients achieve the best possible outcomes. To make an appointment with Dr. Balar, get in touch with RCCA today.
Clinical Interests and expertise
Like many RCCA oncologists, Dr. Balar is a generalist. He has expertise in treating all types of cancers, including both solid tumors and hematological malignancies. Conditions he commonly works with include:
- Breast cancer
- Colon cancer
- Pancreatic cancer
- Liver cancer
- Lung cancer
- Genitourinary cancers
- Lymphomas
- Leukemias
Dr. Balar provides treatment coordination and management for all the above diagnoses and more. When working with patients, he prioritizes the latest advancements. He helps patients choose the treatment path that will provide the best outcome, with options including:
- Chemotherapy: Strong drugs kill fast-growing cancer cells throughout the body.
- Targeted therapy: Medications attack cancer cells with specific molecular traits.
- Immunotherapy: The patient’s own immune system is trained to fight cancer.
These treatments work to control and combat cancer, helping patients recover while maintaining a higher quality of life.
Professional Background and Academic Achievements
Dr. Balar graduated magna cum laude from the University of South Florida College of Medicine.
Dr. Balar currently serves as chairman of the Cancer Committee at CentraState Medical Center. In this capacity, he provides oversight and direction to help the medical center deliver a higher level of care for its patients.
Education & Training
- Medical school: University of South Florida College of Medicine, 1998
- Internship: University of South Florida, Internal Medicine, 2001
- Residency: University of South Florida, Internal Medicine, 2001
- Fellowship: H. Lee Moffitt Cancer Center and Research Institute, Medical Oncology and Hematology, 2004
- Board certifications: Hematology and Medical Oncology
Professional Background and Academic Achievements
Dr. Balar graduated magna cum laude from the University of South Florida College of Medicine.
Dr. Balar currently serves as chairman of the Cancer Committee at CentraState Medical Center. In this capacity, he provides oversight and direction to help the medical center deliver a higher level of care for its patients.
Education & Training
- Medical school: University of South Florida College of Medicine, 1998
- Internship: University of South Florida, Internal Medicine, 2001
- Residency: University of South Florida, Internal Medicine, 2001
- Fellowship: H. Lee Moffitt Cancer Center and Research Institute, Medical Oncology and Hematology, 2004
- Board certifications: Hematology and Medical Oncology
About Bhavesh Balar, MD
Dr. Balar wanted to be a physician ever since early childhood. “The medical profession fulfills my curiosity for medical sciences and advancements,” he explains, “as well as the self-satisfaction of making a difference in a person’s life.” Oncology and hematology are unique in this regard. These fields are constantly evolving with new research and discoveries. They also give oncologists the opportunity to support patients through their most vulnerable moments.
To Dr. Balar, this opportunity is very rewarding. “Practicing oncology has allowed me to appreciate the meaning of my life,” he says. He uses all his knowledge and experience to provide the best care possible during a difficult time. In return, watching patients recover gives him a greater understanding of what is most important in life.
The most valuable lesson he has learned is “to appreciate life for everything it has to offer.” Every experience contributes to making a person who they are. Rather than labeling experiences ‘good’ or ‘bad,’ therefore, Dr. Balar has learned to embrace them all.
He avoids labeling people as well. In his eyes, it is important to treat individuals as more than patients. “I believe in treating a person as a whole,” he explains, “rather than simply looking at the illness.” Cancer behaves differently in every person, and individuals react to it differently as well. Effective treatment must be personalized. He takes every factor into account, including the patient’s overall health, their cancer’s unique molecular makeup, and their personal beliefs, background, and spirituality. This approach helps him develop a care plan to meet the individual’s desires.
To patients beginning cancer care, Dr. Balar urges them to remember that “everything will be okay.” He will be present to assist patients and their loved ones at every step of the journey, providing real hope for recovery or a better quality of life.
“In the past several years,” he adds, “there have been incredible scientific breakthroughs.” Many cancers that were previously thought to be untreatable now have reliable cures. Even cancers that are still incurable can be managed more effectively, letting patients maintain normal lives. With new therapies being discovered at such a rapid pace, it is easier than ever for patients to feel confident about their future. “There is nothing we cannot treat anymore,” Dr. Balar finishes.
Locations
Dr. Balar serves patients at RCCA in Freehold, NJ
Pond View Professional Park, Bldg 300
Freehold NJ 07728
Hospital Affiliations
He is also affiliated with many local hospitals and treatment centers, including:
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.